These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bariatric Arterial Embolization with Calibrated Radiopaque Microspheres and an Antireflux Catheter Suppresses Weight Gain and Appetite-Stimulating Hormones in Swine. Weiss CR; Fu Y; Beh C; Hu C; Kedziorek D; Shin EJ; Anders RA; Arepally A; Kraitchman DL J Vasc Interv Radiol; 2020 Sep; 31(9):1483-1491. PubMed ID: 32800664 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Soluble Gelatin Sponge Particles and Tris-acryl Gelatin Microspheres for Bariatric Arterial Embolization in Swine. Sato H; Sonomura T; Koike M; Matsuzaki I; Shimono R; Furotani H; Murata SI J Vasc Interv Radiol; 2022 Sep; 33(9):1097-1100. PubMed ID: 36049842 [TBL] [Abstract][Full Text] [Related]
6. Bariatric Arterial Embolization: Effect of Microsphere Size on the Suppression of Fundal Ghrelin Expression and Weight Change in a Swine Model. Fu Y; Weiss CR; Paudel K; Shin EJ; Kedziorek D; Arepally A; Anders RA; Kraitchman DL Radiology; 2018 Oct; 289(1):83-89. PubMed ID: 29989526 [TBL] [Abstract][Full Text] [Related]
7. Bariatric Embolization: Pilot Study on the Impact of Gastroprotective Agents and Arterial Distribution on Ulceration Risk and Efficacy in a Porcine Model. Paxton BE; Arepally A; Alley CL; Kim CY J Vasc Interv Radiol; 2016 Dec; 27(12):1923-1928. PubMed ID: 27717647 [TBL] [Abstract][Full Text] [Related]
8. Bariatric Arterial Embolization with Non-spherical Polyvinyl Alcohol Particles for Ghrelin Suppression in a Swine Model. Kim JM; Kim MD; Han K; Muqmiroh L; Kim SU; Kim GM; Kwon J; Park SI; Won JY; Lee DY Cardiovasc Intervent Radiol; 2017 May; 40(5):744-749. PubMed ID: 28184958 [TBL] [Abstract][Full Text] [Related]
9. Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity) Trial: Results at 1 Year. Weiss CR; Abiola GO; Fischman AM; Cheskin LJ; Vairavamurthy J; Holly BP; Akinwande O; Nwoke F; Paudel K; Belmustakov S; Hong K; Patel RS; Shin EJ; Steele KE; Moran TH; Thompson RE; Dunklin T; Ziessman H; Kraitchman DL; Arepally A Radiology; 2019 Jun; 291(3):792-800. PubMed ID: 30938624 [TBL] [Abstract][Full Text] [Related]
10. Microfluidic-prepared, monodisperse, X-ray-visible, embolic microspheres for non-oncological embolization applications. Beh CW; Fu Y; Weiss CR; Hu C; Arepally A; Mao HQ; Wang TH; Kraitchman DL Lab Chip; 2020 Oct; 20(19):3591-3600. PubMed ID: 32869821 [TBL] [Abstract][Full Text] [Related]
11. Bariatric embolization for suppression of the hunger hormone ghrelin in a porcine model. Paxton BE; Kim CY; Alley CL; Crow JH; Balmadrid B; Keith CG; Kankotia RJ; Stinnett S; Arepally A Radiology; 2013 Feb; 266(2):471-9. PubMed ID: 23204538 [TBL] [Abstract][Full Text] [Related]
12. Anatomical and Technical Considerations for Bariatric Embolization. Garcia-Reyes K; Fischman A Tech Vasc Interv Radiol; 2020 Mar; 23(1):100657. PubMed ID: 32192637 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes and Weight Loss After Bariatric Embolization of the Left Gastric Artery. Pirlet C; Ruzsa Z; Nemes B; Poirier P; Bertrand OF J Invasive Cardiol; 2020 Aug; 32(8):310-314. PubMed ID: 32737266 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Uterine Necrosis After Uterine Artery Embolization with Soluble Gelatin Sponge Particles or Tris-acryl Gelatin Microspheres in Swine. Sato H; Sonomura T; Onishi S; Koike M; Tanaka R; Ueda S; Okuhira R; Kamisako A; Koyama T; Shima N; Yamamoto S; Sakai Y; Murata SI; Ikoma A Cardiovasc Intervent Radiol; 2021 Nov; 44(11):1780-1789. PubMed ID: 34231005 [TBL] [Abstract][Full Text] [Related]
15. Feasibility, Safety, and Efficacy of Flow-Diverting Stent-Assisted Microsphere Embolization of Fusiform and Sidewall Aneurysms. Nonn A; Kirschner S; Figueiredo G; Kramer M; Nikoubashman O; Pjontek R; Wiesmann M; Brockmann MA Neurosurgery; 2015 Jul; 77(1):126-35; discussion 135-6. PubMed ID: 25714517 [TBL] [Abstract][Full Text] [Related]
16. Bariatric Embolization: A Narrative Review of Clinical Data From Human Trials. Hafezi-Nejad N; Bailey CR; Weiss CR Tech Vasc Interv Radiol; 2020 Mar; 23(1):100658. PubMed ID: 32192638 [TBL] [Abstract][Full Text] [Related]
17. Rationale and Preclinical Data Supporting Bariatric Arterial Embolization. Fu Y; Kraitchman DL Tech Vasc Interv Radiol; 2020 Mar; 23(1):100656. PubMed ID: 32192641 [TBL] [Abstract][Full Text] [Related]
18. The feasibility of degradable glass microspheres as transient embolic medical devices. Doucet J; MacDonald K; Lee C; Hana RA; Soulez G; Boyd D J Biomater Appl; 2021 Jan; 35(6):615-632. PubMed ID: 32722998 [TBL] [Abstract][Full Text] [Related]
19. A Water-Based Liquid Embolic: Evaluation of its Safety and Efficacy in a Rabbit Kidney Model. Ganguli S; Lareau R; Jarrett T; Soulen MC J Vasc Interv Radiol; 2021 Jun; 32(6):813-818. PubMed ID: 33677119 [TBL] [Abstract][Full Text] [Related]
20. Bariatric embolization: a new and effective option for the obese patient? Weiss CR; Kathait AS Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):293-302. PubMed ID: 28276817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]